Literature DB >> 9326444

H1 and H2 histamine receptors modulate osteoclastic resorption by different pathways: evidence obtained by using receptor antagonists in a rat synchronized resorption model.

C Dobigny1, J L Saffar.   

Abstract

We have previously postulated that mast cells (MC) may act as accessory cells in bone resorption. In this study we obtained evidence that histamine, the most abundant mediator released upon MC degranulation, is one of many factors modulating resorption. As the effect of histamine is mediated through different receptors, we tested the effects of mepyramine (1.5 mg/kg/day) and cimetidine (125 mg/kg/day), that antagonize H1 and H2 receptors, respectively. These effects were assessed morphometrically in a well-defined rat model of synchronized resorption at different stages of the process. On day 4 after induction (i.e., at the peak of resorption in this model), both agents reduced resorption significantly. Mepyramine acted by disturbing osteoclast activation and by reducing osteoclast activity (P < 0.01), while cimetidine principally reduced the size of the osteoclast population (P < 0.01). On day 6 (stage of declining resorption), the same resorption score as on day 4 was maintained in the mepyramine group, mainly through a marked increase in osteoclast activity (P < 0.01). In contrast, cimetidine continued to strongly reduce resorption (P < 0.01) and led to a further drop in the osteoclast population (P < 0.01). One day after induction, nonspecific esterase (NSE)-positive cells (putative osteoclast precursors) were significantly less numerous after treatment with the two agents. Significant changes in the MC population in the vicinity of the zone undergoing resorption occurred on days 4 and 6. The periosteal microvasculature adjacent to the reference bone zone was also markedly modified, especially in the cimetidine group. These results show that histamine intervenes in resorption through both H1 and H2 receptors. However, the mechanisms triggered by these receptors were quite different: H2 receptors appeared to be more strategic, as no replenishment of the osteoclast population occurred after the initial depletion in precursors. Histamine also appears to influence other neighbouring compartments, in which disturbances are probably linked to defective resorption. These findings support our hypothesis by which MC are accessory cells of resorption in this model.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9326444     DOI: 10.1002/(SICI)1097-4652(199710)173:1<10::AID-JCP2>3.0.CO;2-M

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  21 in total

1.  Increased bone fracture prevalence in postmenopausal women suffering from pollen-allergy.

Authors:  Viktoria Ferencz; Szilvia Meszaros; Emoke Csupor; Edit Toth; Katalin Bors; Andras Falus; Csaba Horvath
Journal:  Osteoporos Int       Date:  2006-01-24       Impact factor: 4.507

2.  Use of acid-suppressive drugs and risk of fracture: a meta-analysis of observational studies.

Authors:  Chun-Sick Eom; Sang Min Park; Seung-Kwon Myung; Jae Moon Yun; Jeong-Soo Ahn
Journal:  Ann Fam Med       Date:  2011 May-Jun       Impact factor: 5.166

3.  Effects of experimental osteoporosis and low calcium intake on postextraction sockets of rats.

Authors:  Renata F D Prado; Vanessa Á S Silveira; Rosilene F D Rocha; Luana M R D Vasconcellos; Yasmin R Carvalho
Journal:  Int J Exp Pathol       Date:  2012-02-24       Impact factor: 1.925

Review 4.  Risk of fracture and pneumonia from acid suppressive drugs.

Authors:  Chun-Sick Eom; Sang-Soo Lee
Journal:  World J Methodol       Date:  2011-09-26

Review 5.  Prevalence, pathogenesis, and treatment options for mastocytosis-related osteoporosis.

Authors:  M Rossini; R Zanotti; G Orsolini; G Tripi; O Viapiana; L Idolazzi; A Zamò; P Bonadonna; V Kunnathully; S Adami; D Gatti
Journal:  Osteoporos Int       Date:  2016-02-18       Impact factor: 4.507

6.  Systemic mastocytosis with skeletal involvement: a case report and review of the literature.

Authors:  Maurizio Benucci; Catia Bettazzi; Stefania Bracci; Plinio Fabiani; Laura Monsacchi; Carlo Cappelletti; Mariangela Manfredi; Stefania Ciolli
Journal:  Clin Cases Miner Bone Metab       Date:  2009-01

7.  Mast cells and MMP-9 in the lamina propria during eruption of rat molars: quantitative and immunohistochemical evaluation.

Authors:  Paulo Sérgio Cerri; Jorge Alonso Pereira-Júnior; Natalia Barrionuevo Biselli; Estela Sasso-Cerri
Journal:  J Anat       Date:  2010-06-16       Impact factor: 2.610

8.  Targeted deletion of histidine decarboxylase gene in mice increases bone formation and protects against ovariectomy-induced bone loss.

Authors:  L A Fitzpatrick; E Buzas; T J Gagne; A Nagy; C Horvath; V Ferencz; A Mester; B Kari; M Ruan; A Falus; J Barsony
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-25       Impact factor: 11.205

9.  Antihistamine therapy and bone mineral density: analysis in a population-based US sample.

Authors:  Mitsuyo Kinjo; Soko Setoguchi; Daniel H Solomon
Journal:  Am J Med       Date:  2008-12       Impact factor: 4.965

10.  Systemic mastocytosis presenting as osteoporosis--a case report.

Authors:  R Mathew; V Dhillon; P Shepherd
Journal:  Clin Rheumatol       Date:  2009-03-21       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.